• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T-0509对β-肾上腺素能受体药理特性的分子表征

Molecular characterization of pharmacological properties of T-0509 for beta-adrenoceptors.

作者信息

Sato Y, Kurose H, Isogaya M, Nagao T

机构信息

Department of Toxicology and Pharmacology, Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

出版信息

Eur J Pharmacol. 1996 Nov 21;315(3):363-7. doi: 10.1016/s0014-2999(96)00648-6.

DOI:10.1016/s0014-2999(96)00648-6
PMID:8982677
Abstract

The pharmacological properties of T-0509, (-)-(R)-1-(3,4-dihydroxyphenyl)-2-[(3,4-dimethoxyphenethyl)amino]ethanol, were compared with those of isoproterenol. In the radioligand binding studies of [125I]iodocyanopindolol with COS-7 cell membranes that transiently expressed beta-adrenoceptor subtypes, T-0509 exhibited 11- and 97-fold greater Ki values for beta 2- and beta 3-adrenoceptors, respectively, compared with beta 1-adrenoceptors. Affinities of beta 2- and beta 3-adrenoceptors to isoproterenol were 1.4- and 28-fold lower than that of beta 1-adrenoceptors, respectively. The maximal stimulatory effects of T-0509 on adenylyl cyclase of CHO-K1 (chinese hamster ovary K1) cell membranes expressing beta 1- or beta 2-adrenoceptors were 85% or 96% of those produced by isoproterenol, respectively. These results indicate that T-0509 is a relatively specific beta 1-adrenoceptor agonist with a high intrinsic activity as compared with isoproterenol.

摘要

将(-)-(R)-1-(3,4-二羟基苯基)-2-[(3,4-二甲氧基苯乙基)氨基]乙醇(T-0509)的药理特性与异丙肾上腺素的药理特性进行了比较。在[125I]碘氰吲哚洛尔与瞬时表达β-肾上腺素能受体亚型的COS-7细胞膜的放射性配体结合研究中,与β1-肾上腺素能受体相比,T-0509对β2-和β3-肾上腺素能受体的Ki值分别高11倍和97倍。β2-和β3-肾上腺素能受体对异丙肾上腺素的亲和力分别比β1-肾上腺素能受体低1.4倍和28倍。T-0509对表达β1-或β2-肾上腺素能受体的CHO-K1(中国仓鼠卵巢K1)细胞膜腺苷酸环化酶的最大刺激作用分别为异丙肾上腺素产生作用的85%或96%。这些结果表明,与异丙肾上腺素相比,T-0509是一种具有高内在活性的相对特异性的β1-肾上腺素能受体激动剂。

相似文献

1
Molecular characterization of pharmacological properties of T-0509 for beta-adrenoceptors.T-0509对β-肾上腺素能受体药理特性的分子表征
Eur J Pharmacol. 1996 Nov 21;315(3):363-7. doi: 10.1016/s0014-2999(96)00648-6.
2
Molecular characterization of pharmacological properties and selectivity of SWR-0315NA for beta3-adrenoceptors.SWR-0315NA对β3肾上腺素能受体的药理学特性及选择性的分子特征
Biol Pharm Bull. 2004 May;27(5):718-22. doi: 10.1248/bpb.27.718.
3
Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.(-)-RO363 对人心脏β-肾上腺素能受体亚型、人克隆β3-肾上腺素能受体及啮齿动物肠道β3-肾上腺素能受体的作用。
Br J Pharmacol. 1997 Jan;120(2):165-76. doi: 10.1038/sj.bjp.0700850.
4
Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor.β3肾上腺素能受体的物种同源物对大多数非典型效应的介导作用。
Br J Pharmacol. 1994 Jul;112(3):911-9. doi: 10.1111/j.1476-5381.1994.tb13167.x.
5
Relationship between desensitization and downregulation of beta-adrenoceptors in cardiac tissues after prolonged in vivo infusion of T-0509, a beta 1-adrenoceptor agonist.
Jpn J Pharmacol. 1997 Apr;73(4):325-32. doi: 10.1254/jjp.73.325.
6
Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.一些新合成的苯乙醇胺和苯氧丙醇胺化合物对重组人β-和α1-肾上腺素能受体亚型的结合亲和力比较。
J Pharm Pharmacol. 2005 Jan;57(1):75-81. doi: 10.1211/0022357055074.
7
Selectivity and potency of agonists for the three subtypes of cloned human beta-adrenoceptors expressed in Chinese hamster ovary cells.在中国仓鼠卵巢细胞中表达的克隆人β-肾上腺素能受体三种亚型激动剂的选择性和效价。
Tohoku J Exp Med. 2000 Nov;192(3):181-93. doi: 10.1620/tjem.192.181.
8
Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.牛骨骼肌和脂肪组织膜中β-肾上腺素能受体配体的经典和非典型结合位点以及腺苷酸环化酶的激活
Br J Pharmacol. 1994 Mar;111(3):866-72. doi: 10.1111/j.1476-5381.1994.tb14818.x.
9
Beta-adrenoceptor subtype activities of trimetoquinol derivatives: biochemical studies on human beta-adrenoceptors expressed in chinese hamster ovary cells.曲美喹诺衍生物的β-肾上腺素能受体亚型活性:对中国仓鼠卵巢细胞中表达的人β-肾上腺素能受体的生化研究
J Pharmacol Exp Ther. 1999 Nov;291(2):875-83.
10
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.犬脂肪细胞中β1-、β2-和β3-肾上腺素能受体的共存及其对儿茶酚胺的不同激活作用。
Am J Physiol. 1993 Mar;264(3 Pt 1):E403-12. doi: 10.1152/ajpendo.1993.264.3.E403.

引用本文的文献

1
A Focus on Unusual ECL2 Interactions Yields β -Adrenergic Receptor Antagonists with Unprecedented Scaffolds.聚焦于不寻常的 ECL2 相互作用,得到具有前所未有的支架的β-肾上腺素受体拮抗剂。
ChemMedChem. 2020 May 19;15(10):882-890. doi: 10.1002/cmdc.201900715. Epub 2020 Apr 17.
2
The luminescent HiBiT peptide enables selective quantitation of G protein-coupled receptor ligand engagement and internalization in living cells.该发光 HiBiT 肽能够在活细胞中选择性定量测定 G 蛋白偶联受体配体结合和内化。
J Biol Chem. 2020 Apr 10;295(15):5124-5135. doi: 10.1074/jbc.RA119.011952. Epub 2020 Feb 27.
3
Signalling in response to sub-picomolar concentrations of active compounds: Pushing the boundaries of GPCR sensitivity.
对皮摩尔级浓度的活性化合物的信号响应:推动 GPCR 敏感性的极限。
Br J Pharmacol. 2019 Jul;176(14):2382-2401. doi: 10.1111/bph.14636. Epub 2019 Apr 5.
4
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.《2013/14药理学简明指南:G蛋白偶联受体》
Br J Pharmacol. 2013 Dec;170(8):1459-581. doi: 10.1111/bph.12445.